BIRD—Evidence to Decision Framework Meeting for Ivermectin’s Efficacy:
The British Ivermectin Recommendation Development (BIRD) panel included dozens of multinational scientists and doctors discussing the mounting data points and evidence supporting the use of Ivermectin for COVID-19 cases. The large, diverse group reviewed the evidence associated with ivermectin to potentially prevent and treat COVID-19, with a goal of reaching a consensus and making recommendations for further investigation and/or use.
Sheba Medical Center Affiliated Principal Investigator Discusses the Successful Ivermectin Study for Mild COVID-19:
Professor Eli Schwarz, the Director of the Center for Geographic Medicine at Sheba Medical Center in Tel-Hashomer, Israel, reported on the success of a randomly controlled, double-blind clinical trial showing that the generic drug ivermectin materially reduces COVID-19 viral shedding. His study, well designed and conducted in one of the top health centers in the world, reveals that, in fact, ivermectin does reduce viral shedding overall in patients with COVID-19. Although the patient sample was not sufficiently sized, the data findings supports that the off-label FDA-approved drug can reduce infectivity duration.